NASDAQ:ITMR

Itamar Medical (ITMR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$30.87
$30.87
50-Day Range
$30.54
$30.87
52-Week Range
$16.36
$30.91
Volume
N/A
Average Volume
90,796 shs
Market Capitalization
$497.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ITMR stock logo

About Itamar Medical Stock (NASDAQ:ITMR)

Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets two products, namely, WatchPAT and EndoPAT. The WatchPAT diagnoses sleep apnea, which has been proven to be a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a proven predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur on January 15, 1997 and is headquartered in Caesarea, Israel.

ITMR Stock News Headlines

ITMR Historical Data
Read Your Way Around the World
The “Next Bitcoin”? 10 CENT Crypto Set to Explode
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
Find the Best Medical Schools
Sarit Packer and Itamar Srulovich
ZOLL Announces Closing of Acquisition of Itamar Medical
The “Next Bitcoin”? 10 CENT Crypto Set to Explode
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
Itamar Medical ADSs Rally on Zoll Medical Deal >ITMR
Itamar Medical Earnings Miss, Revenue Beats In Q2
See More Headlines
Receive ITMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Itamar Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/18/2021
Today
4/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:ITMR
Fax
N/A
Employees
257
Year Founded
1997

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$41.03 million

Miscellaneous

Free Float
N/A
Market Cap
$497.25 million
Optionable
Not Optionable
Beta
0.73

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Gilad Glick
    President, CEO & VP-Sales & Marketing
  • Shy Basson
    Chief Financial Officer
  • Efrat Litman
    Vice President-Advanced Research & Development
  • Jennifer Cook
    Global Medical Director
  • Eilon Livne
    VP-Sales & Channels Development

ITMR Stock Analysis - Frequently Asked Questions

How were Itamar Medical's earnings last quarter?

Itamar Medical Ltd. (NASDAQ:ITMR) announced its earnings results on Thursday, November, 18th. The company reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.17) by $0.32. The company had revenue of $13.57 million for the quarter, compared to analysts' expectations of $13.70 million.

What other stocks do shareholders of Itamar Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Itamar Medical investors own include Gilead Sciences (GILD), AbbVie (ABBV), Carnival Co. & (CCL), Energy Transfer (ET), KeyCorp (KEY), Occidental Petroleum (OXY), Pfizer (PFE), Wells Fargo & Company (WFC) and Abbott Laboratories (ABT).

Does Itamar Medical have any subsidiaries?
The following companies are subsidiares of Itamar Medical: I.M.E. 2016 B.V., Itamar Medical Inc., and Itamar Medical Japan Co. Ltd..
Read More
This page (NASDAQ:ITMR) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners